Silence Therapeutics plc Restructuring Charges
Silence Therapeutics plc (SLNCF) reported Restructuring Charges of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-10
- Silence Therapeutics plc restructuring charges for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Silence Therapeutics plc restructuring charges for the quarter ending 2025-12-31 was $0.00.
- Silence Therapeutics plc restructuring charges for the quarter ending 2025-09-30 was $0.00.
- Silence Therapeutics plc restructuring charges for the quarter ending 2025-06-30 was $1.32M.
- Silence Therapeutics plc restructuring charges for fiscal 2025 was $1.32M.
- Silence Therapeutics plc restructuring charges for fiscal 2024 was $0.00.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $1.32M derived: sum of 3 quarters · filed 2026-08-10 | $1.32M 10-K · filed 2026-03-05 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $1.32M derived: sum of 2 quarters · filed 2026-08-10 | $1.32M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.32M 10-Q · filed 2026-08-10 | $1.32M 10-Q · filed 2026-08-10 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | $0.00 10-K · filed 2026-03-05 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 |